Michal Smida, MSc, PhD

Research group leader
Central European Institute of Technology (CEITEC), Masaryk University; Department of Internal Medicine - Hematology and Oncology, Medical Faculty of Masaryk University and University Hospital Brno, Czech Republic

N/A

Poster(s):

• 1001 - Identification of novel targets that upregulate CD20 expression in rituximab-resistant cells with the use of genome-wide CRISPR screening